Despite the recent decrease in overall prevalence of Helicobacter pylori infection, morbidity
and mortality rates associated with gastric cancer remain high. The antimicrobial resistance …

Increasing rates of Helicobacter pylori resistance are associated with multiple clinical
challenges. Bacterial factors linked to H. pylori resistance are mutations, efflux pumps, and …

Background The increasing prevalence of antibiotic resistance in cases of Helicobacter
pylori (H. pylori) infection has emerged as a significant global issue. This study offers a …

Background As the reduced eradication rate of Helicobacter pylori (H. pylori), we introduced
string‐test and quantitative PCR (qPCR) for susceptibility‐guided therapy innovatively. The …

Helicobacter pylori (H. pylori) infection is a prevalent global health issue, associated with
several gastrointestinal disorders, including gastritis, peptic ulcers, and gastric cancer. The …

Abstract Background Treatment of Helicobacter pylori (H. pylori) infection has become
challenging following the development of primary antibiotic resistance. A primary therapeutic …

As the rate of discovery of drug-resistant Helicobacter pylori cases increases worldwide, the
relevant societies have updated their guidelines for primary eradication regimens. A …

Helicobacter pylori is a pathogenic bacterium associated with various gastrointestinal
diseases, including chronic gastritis, peptic ulcers, mucosa-associated lymphoid tissue …

Helicobacter pylori infections, as one of the most prevalent among humans, are generally
acquired during childhood, and are one of the main causes of chronic gastritis and peptic …

Persistent infection with Helicobacter pylori (H. pylori) is an important factor in gastric
diseases. The vacA and cagA virulence factors of H. pylori contribute to the development of …